| dCCA | distal cholangiocarcinoma |
| OS | overall survival |
| CINS | Cholangiocarcinoma Inflammation–Nutrition Score |
| CA19-9 | carbohydrate antigen 19-9 |
| TNM | tumor–node–metastasis |
| DFS | disease-free survival |
| IL-6 | interleukin-6 |
| TNF-α | tumor necrosis factor-alpha |
| CAR | C-reactive protein-to-albumin ratio |
| NLR | neutrophil-to-lymphocyte ratio |
| PNI | prognostic nutritional index |
| PLR | platelet-to-lymphocyte ratio |
| AJCC | American Joint Committee on Cancer |
| ERCP | endoscopic retrograde cholangiopancreatography |
| PTBD | percutaneous transhepatic biliary drainage |
| IQR | interquartile range |
| R0 | no residual tumor |
| HR | hazard ratio |
| CI | confidence interval |
| VIF | variance inflation factor |
| AUC | area under the curve |
| ROC | receiver operating characteristic |
| DCA | decision curve analysis |
| NRI | net reclassification improvement |
| IDI | integrated discrimination improvement |
| PDGF | platelet-derived growth factor |
| STAT3 | signal transducer and activator of transcription 3 |
| HCC | hepatocellular carcinoma |
| PIPL | Personal Information Protection Law |
| ctDNA | circulating tumor DNA |